These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Williams AR; Hare JM Circ Res; 2011 Sep; 109(8):923-40. PubMed ID: 21960725 [TBL] [Abstract][Full Text] [Related]
13. Use of mesenchymal stem cells for therapy of cardiac disease. Karantalis V; Hare JM Circ Res; 2015 Apr; 116(8):1413-30. PubMed ID: 25858066 [TBL] [Abstract][Full Text] [Related]
14. Role of prostaglandin E2 in allogeneic mesenchymal stem cell therapy for cardiac repair. Sareen N; Srivastava A; Dhingra S Can J Physiol Pharmacol; 2021 Feb; 99(2):140-150. PubMed ID: 33559528 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells in Cardiology. White IA; Sanina C; Balkan W; Hare JM Methods Mol Biol; 2016; 1416():55-87. PubMed ID: 27236666 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Applications of Mesenchymal Stem Cells: A Comprehensive Review. Samadi P; Saki S; Manoochehri H; Sheykhhasan M Curr Stem Cell Res Ther; 2021; 16(3):323-353. PubMed ID: 32928093 [TBL] [Abstract][Full Text] [Related]
17. Cell-based therapies for cardiac disease: a cellular therapist's perspective. Young PP; Schäfer R Transfusion; 2015 Feb; 55(2):441-51; quiz 440. PubMed ID: 25145464 [TBL] [Abstract][Full Text] [Related]
18. Comparative Characterization of Ischemia-Induced Brain Multipotent Stem Cells with Mesenchymal Stem Cells: Similarities and Differences. Sakuma R; Takahashi A; Nakano-Doi A; Sawada R; Kamachi S; Beppu M; Takagi T; Yoshimura S; Matsuyama T; Nakagomi T Stem Cells Dev; 2018 Oct; 27(19):1322-1338. PubMed ID: 29999479 [TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis. Chen R; Cai X; Liu J; Bai B; Li X Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841 [TBL] [Abstract][Full Text] [Related]
20. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD; Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]